NCT04947319
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04947319
Title Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ono Pharmaceutical Co. Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham School of Medicine Birmingham Alabama 35233 United States Details
Mayo Clinic- Phoenix Phoenix Arizona 85054 United States Details
City of Hope Comprehensive Breast Cancer Center Duarte California 91010 United States Details
University of California, Irvine Irvine California 92868 United States Details
Stanford University Palo Alto California 94304 United States Details
University of Colorado Denver Aurora Colorado 80045 United States Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
Georgetown University, Lombardi Comprehensive Cancer Center Washington D.C. District of Columbia 20037 United States Details
Mayo Clinic- Jacksonville Jacksonville Florida 32224 United States Details
University of Miami-Sylvester Cancer Center Miami Florida 33136 United States Details
Orlando Health Orlando Florida 32806 United States Details
Moffitt Cancer Center- Miami Pembroke Pines Florida 33028 United States Details
Piedmont Healthcare Atlanta Georgia 30318 United States Details
University of Kentucky Lexington Kentucky 40536 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute - Brigham & Women's Hospital Boston Massachusetts 02215 United States Details
University Of Michigan Ann Arbor Michigan 41809 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
The University of Kansas Cancer Center (KUCC) (Kansas City Cancer Center (KCCC)) - North Kansas City Missouri 64154 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Hackensack University Medical Center - John Theurer Cancer Hackensack New Jersey 07601 United States Details
Roswell Park Comprehensive Cancer Center (RPCCC) (Roswell Park Cancer Institute (RPCI)) Buffalo New York 14263 United States Details
Memorial Sloan Kettering New York New York 10022 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Levine Cancer Center Charlotte North Carolina 28204 United States Details
Duke University School of Medicine Durham North Carolina 27705 United States Details
Cleveland Clinic Cleveland Ohio 44106 United States Details
Providence Health Cancer Center Portland Oregon 97239 United States Details
Penn State Hershey Cancer Center Hershey Pennsylvania 17033 United States Details
Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Hillman Cancer Center, University of Pittsburgh Pittsburgh Pennsylvania 15232 United States Details
Lifespan Rhode Island Hospital Providence Rhode Island 02903 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
Houston Methodist Research Institute (HMRI) Houston Texas 77030 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
The University of Utah - Huntsman Cancer Institute (HCI) Salt Lake City Utah 84112 United States Details
The University of Vermont - Fletcher Allen Health Care Burlington Vermont 05401 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field